Michael I. Mackness

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Helen M. Colhoun, D. J. Betteridge, Paul N. Durrington et al. · The Lancet · 2004 · 3.8K citations

Metabolic Syndrome, Primary Prevention, Diabetes Management +8

Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein

Michael I. Mackness, Sharon Arrol, Paul N. Durrington · FEBS Letters · 1991 · 974 citations

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

Michael I. Mackness, D. W. S. Harty, Deepak Bhatnagar et al. · Atherosclerosis · 1991 · 491 citations

Metabolic Syndrome, Serum Paraoxonase Activity, Medicine +8

Paraoxonase Status in Coronary Heart Disease

Bharti Mackness, Gershan K. Davies, Wajdi Turkie et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2001 · 434 citations

Lipid Peroxidation, Hyperlipidemia, Oxidative Stress +17

Low Paraoxonase Activity Predicts Coronary Events in the Caerphilly Prospective Study

Bharti Mackness, Paul N. Durrington, Patrick McElduff et al. · Circulation · 2003 · 421 citations · Full text